scorecardresearch Skip to main content

More Life Sciences Headlines

Thermo Fisher just opened a $180 million plant. Executives already are talking about expanding.

The two-story building in Plainville underscores the company’s commitment to the growing field of gene therapy, which has given hope to people with deadly inherited diseases.

Demand for life sciences lab space has slowed in Boston area and nationally, report says

Real estate giant JLL depicted an overbuilt market that is forcing building owners, who only recently commanded top dollar for premium lab space, to reduce rents and scramble for tenants.

Shares of biotech Neumora retreat after raising $250 million in IPO

Neumora's stock began trading early Friday afternoon with the ticker NMRA, and quickly fell 7.3 percent on a day of broad market declines.

Saudi fund sets up in Boston to plow $1 billion a year into research and drugs to extend life

The source of funding may present a dilemma for some scientists and entrepreneurs because of the kingdom’s record on human rights.

Vertex scientists share $3 million prize for developing the company’s cystic fibrosis drugs

Their work has dramatically extended the life expectancy of CF patients.

Generate Biomedicines raises $273 million in latest round of funding

The money arrives amid a slump in biotech investments this year, as investors stick to the sidelines because of economic uncertainty and interest rate hikes.

FDA advisers are lukewarm about expanding use of Alnylam drug to heart patients

The experts agreed with FDA scientists that the benefits to patients in a clinical trial compared to a placebo were modest at best.


CVS, Walgreens illegally marketed ‘unapproved’ eye drops, FDA says

CVS and Walgreens claim to have stopped selling the eye drops, and consumers who previously purchased them can get full refunds.